Emglif-M 12.5mg/500mg Tablet is an oral antidiabetic medicine containing Empagliflozin 12.5mg and Metformin Hydrochloride 500mg. It is used along with diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus.

This combination provides dual action for diabetes management. Empagliflozin belongs to the SGLT2 inhibitor class and helps remove excess glucose through urine, while Metformin helps reduce glucose production in the liver and improves insulin sensitivity.

Uses of Emglif-M 12.5mg/500mg Tablet

• Management of type 2 diabetes mellitus
• Helps control high blood sugar levels
• Improves insulin sensitivity
• Helps reduce glucose production by the liver
• Helps improve overall glycemic control when combined with diet and exercise

Benefits of Emglif-M 12.5mg/500mg Tablet

• Combines two diabetes medicines in one tablet
• Provides dual-action blood sugar control
• Helps lower blood glucose levels through different mechanisms
• Supports improved insulin response and glucose utilization
• Convenient oral tablet formulation for diabetes management

Dosage & Administration

• Take Emglif-M exactly as prescribed by your doctor.
• Swallow the tablet whole with water; do not crush or chew.
• It is usually taken with meals to reduce stomach-related side effects.
• Dosage depends on blood sugar levels, kidney function, and individual treatment requirements.
• Regular monitoring of blood glucose levels is recommended.

Prescription Required: Yes. Use only under medical supervision.

How Emglif-M Works

Empagliflozin:

Empagliflozin blocks the SGLT2 protein in the kidneys, reducing glucose reabsorption and increasing glucose removal through urine.

Metformin:

Metformin decreases glucose production in the liver and improves the body’s sensitivity to insulin, helping lower blood sugar levels.

Possible Side Effects

Some people may experience:

• Nausea
• Diarrhea
• Stomach discomfort
• Gas or bloating
• Loss of appetite
• Increased urination
• Urinary tract infections
• Genital infections

Rare but serious side effects may include lactic acidosis related to Metformin or dehydration-related problems. Contact your doctor if you experience unusual weakness, breathing difficulty, or severe symptoms.

Q1: What is Emglif-M 12.5mg/500mg Tablet used for?

Emglif-M is used to control blood sugar levels in adults with type 2 diabetes along with diet and exercise.

Q2: What are the active ingredients in Emglif-M?

It contains Empagliflozin 12.5mg and Metformin Hydrochloride 500mg.

Q3: Can Emglif-M be used for type 1 diabetes?

No. It is intended for the treatment of type 2 diabetes mellitus.

Q4: How should Emglif-M 12.5mg/500mg be taken?

Take it exactly as prescribed by your doctor, usually with food, and maintain regular blood sugar monitoring.

Q5: Can I stop taking Emglif-M if my sugar improves?

Do not stop or change your diabetes medication without consulting your healthcare provider.